ENVESTNET ASSET MANAGEMENT INC - ANTARES PHARMA INC ownership

ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 161 filers reported holding ANTARES PHARMA INC in Q4 2019. The put-call ratio across all filers is 5.95 and the average weighting 0.1%.

Quarter-by-quarter ownership
ENVESTNET ASSET MANAGEMENT INC ownership history of ANTARES PHARMA INC
ValueSharesWeighting
Q1 2022$79,000
+1.3%
19,231
-11.8%
0.00%
Q4 2021$78,000
+32.2%
21,810
+35.2%
0.00%
Q3 2021$59,000
+9.3%
16,128
+30.4%
0.00%
Q2 2021$54,000
-60.6%
12,367
-78.7%
0.00%
Q1 2020$137,000
-53.1%
58,136
-6.5%
0.00%
Q4 2019$292,000
+65.9%
62,167
+18.5%
0.00%
Q3 2019$176,000
+12.1%
52,478
+10.0%
0.00%
Q2 2019$157,000
+12.9%
47,698
+3.8%
0.00%
Q1 2019$139,00045,9330.00%
Other shareholders
ANTARES PHARMA INC shareholders Q4 2019
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 3,130,192$12,834,0005.32%
Velan Capital Investment Management LP 1,346,971$5,523,0005.12%
FIRST WILSHIRE SECURITIES MANAGEMENT INC 2,799,953$11,480,0004.03%
Sargent Investment Group, LLC 3,663,275$15,019,0003.78%
PERKINS CAPITAL MANAGEMENT INC 481,483$1,974,0001.62%
Rubric Capital Management LP 10,900,000$44,690,0001.62%
ORACLE INVESTMENT MANAGEMENT INC 1,720,000$7,052,0001.39%
Long Focus Capital Management, LLC 540,000$2,214,0000.28%
OBERWEIS ASSET MANAGEMENT INC/ 344,200$1,411,0000.28%
FIRETHORN WEALTH PARTNERS, LLC 84,069$345,0000.26%
View complete list of ANTARES PHARMA INC shareholders